In today’s unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability.

For example ... Also banned is the sale of the A100, of which DeepSeek presumably owns around 10,000 units, which were purchased around 2020 with the profit from the High Flyer Quant Fund.

We've also announced the $1 billion sale of Donlin, the first step in rationalizing ... a long-term partner in the country. It's a powerful example of how responsible mining done right can rebuild ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

The former home of Philadelphia Flyers star and Stanley Cup champion Bobby Clarke is up for sale with a listing price of $1.2 million. Sitting on approximately 1.5 acres, the 5,266-square-foot ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

ASX-listed Dimerix has landed one of the biggest licensing deals by an Australian biotechnology company ... to $940 million in payments for future sales of its kidney disease drug.

Q1 U.S. Brukinsa sales rose 60% YoY to $563 million ... first-quarter 2025 financial results on Wednesday. The Chinese biotech reported adjusted earnings per ADS of $1.22, a turnaround from ...

Krystal Biotech KRYS reported first-quarter 2025 earnings ... Revenues came in solely from the sales of Vyjuvek. Shares of the company are trading down in response to the disappointing results.

Your chance to own the former mansion of a retired Philadelphia Flyers star and two-time Stanley Cup champion is possible — for the right price, of course. The former home of Bobby Clarke is ...